GL1X · GenesisL1 explorer

Research workbench

Crystal structure of an anti-SARS-cov-2 human neutralizing antibody Fab fragment, C135

Analyse Crystal structure of an anti-SARS-cov-2 human neutralizing antibody Fab… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7K8R
Type
protein
Length
434 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
C135 Fab heavy chain; C135 Fab light chain
Pockets
4 · best druggability 0.56

Structure

x-ray diffraction · 2 distinct chains · 8% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HC135 Fab heavy chainprotein22010% helix, 47% strand—
LC135 Fab light chainprotein2146% helix, 50% strand—

Ligands and binding sites

  • GOL · Glycerol · additive · 3 copies · chains H, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13700.560.7552empty
22480.540.7736empty
31460.430.7524empty
4500.280.7519empty

Interfaces

1 interface between chains.

  • H–L · 1856 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 7K8R · Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C135 · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.